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Objective: HLA-B*58:45 is a low-incidence allele in the human leukocyte antigen-B (HLA) locus. The aim
of this study is to conﬁrm the ethnicity of B*58:45 and its deduced probable HLA-associated haplotype in
Taiwanese unrelated bone marrow hematopoietic stem cell donors.
Materials and methods: A total of 40,000 healthy unrelated volunteer bone marrow stem cell donors
(aged, 20e45 years) were tested using a sequence-based typing method. We conﬁrmed the low-
incidence allele B*58:45 in Taiwanese donors. Polymerase chain reaction was performed to amplify
exon 2 and exon 3 of the HLA-A and HLA-B loci and exon 2 of the HLA-DRB1 locus using group-speciﬁc
primer sets. The amplicons were sequenced in both directions with the BigDye Terminator Cycle
Sequencing Ready Reaction Kit according to the manufacturer's protocols.
Results: The DNA sequence of B*58:45 is identical to B*58:01:01 in exon 2 and exon 3 except for residue
595, where G is changed to A (codon 175, GGG/AGG). The nucleotide replacement causes an amino acid
change at codon 175 where G (glycine) of B*58:01:01 is replaced by R (arginine). We deduced the
probable HLA haplotype associated with B*58:45 in Taiwanese donors to be A*33-B*58:45-DRB1*03.
Conclusion: Information on this deduced probable HLA haplotype in association with the low-incidence
B*58:45 allele is of value for HLA testing laboratories for reference purposes and can help bone marrow
donor registries ﬁnd compatible donors for patients with this uncommon HLA allele.
Copyright © 2015, Buddhist Compassion Relief Tzu Chi Foundation. Published by Elsevier Taiwan LLC. All
rights reserved.1. Introduction
The human leukocyte antigen (HLA) genes are characterized by
their extreme allelic polymorphism and by their variations and
diversity in different ethnic groups and racial populations. New
HLA alleles continue to be discovered and the recognition of HLA
low-incidence alleles has enriched our understanding of the
complexity of the HLA system. The genes encoding the HLA allelestics, Tzu Chi Cord Blood Bank
ist Tzu Chi Stem Cells Centre,
Chung-Yang Road, Hualien,
7851.
).
elief Tzu Chi Foundation. Publisheare located in the major histocompatibility complex class I and II
regions. HLA molecules have been deﬁnitely deﬁned as transplant
antigens and have a strong relevance to tissue transplantation. The
similarity of these molecules in donors and recipients is being
considered a predictive factor for graft survival and graft versus
host disease. It is imperative to precisely characterize any unknown
and low-incidence alleles encountered during routine HLA typing
procedures. To facilitate successful, comprehensive unrelated bone
marrow hematopoietic stem cell donor searches for patients in
need of hematopoietic stem cell transplantation, persistent effort is
needed to resolve unidentiﬁed, ambiguous, and low-incidence al-
leles to offer better HLA matching and donor selection.
HLA-B*58:45, a rare-frequency allele (http://www.
allelefrequencies.net/hla6006a.asp), was ﬁrst reported to thed by Elsevier Taiwan LLC. All rights reserved.
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on the associated HLA haplotype of the source individual [1]. The
discovery of B*58:45 from an unknown HLA-B locus allele was the
initial step in the identiﬁcation of this previously unknown HLA
allele. We report here the deduced plausible HLA haplotype in as-
sociationwith B*58:45, based on our observation of four Taiwanese
unrelated bonemarrow stem cell donors. Clinically, recognizing the
Taiwanese ethnicity of B*58:45 can help bone marrow donor reg-
istries allocate stem cell donors for patients carrying B*58:45.
2. Materials and methods
We tested 40,000 healthy unrelated volunteer bone marrow
stem cell donors (aged, 20e45 years) in this study. Peripheral
whole-blood samples from donors with Taiwanese ethnicity were
collected in acid citrate dextrose (ACD) anticoagulant. Formal
written consent was signed by the donors before blood collection.
The ACD whole-blood samples were stored at 80C until use.
Genomic DNAwas extracted using the QIAamp DNA Blood Mini Kit
according to the manufacturer's instructions (QIAGEN, Hilden,
Germany). The DNA material was subjected to HLA genotyping for
the HLA-A, HLA-B, and HLA-DRB1 loci using a commercial poly-
merase chain reaction sequencing-based typing kit (SeCore A/B/
DRB1 locus sequencing kit; Life Technologies, Brown Deer, WI,
USA). High-resolution allelic sequencing was performed as previ-
ously described [2e6]. The two sets of primer sequences used were
as follows: (1) B-CG: M13-BIN1-CGG (sense): TGTAAAACGACGGC-
CAGTCGGGGGCGCAGGACCCGG; P30 exon 5B (antisense):
GCTCCGATGACCACAACTGCT and (2) B-TA: M13-BIN1-TGA (sense):
TGTAAAACGACGGCCAGTGGCGGGGGCGCAGGACCTGA; P30 exon 5B
(antisense): GCTCCGATGACCACAACTGCT. The amplicons were
sequenced using the BigDye Terminator Cycle Sequencing ReadyFig. 1. The raw sequence data (forward and reverse strains) show that the nucleotide G
cDNA ¼ complementary DNA.Reaction Kit (Applied Biosystems, Foster City, CA, USA) in both
directions.
3. Results
Using a sequence-based typing method in 40,000 unrelated
volunteer bone marrow stem cell donors, we detected four donors
bearing the low-incidence B*58:45 allele. We conﬁrmed that the
DNA sequence of B*58:45 is identical to B*58:01:01 in exons 2 and
3, except for substitution of one nucleotide at residue 595 (G/A,
codon 175 GGG/AGG; Fig. 1), which results in replacement of one
amino acid at the amino acid position 175 (G/R; Fig. 2). The
extended HLA-A, HLA-B, and HLA-DRB1 typing of the four unre-
lated bone marrow hematopoietic stem cell donors in our registry
is shown in Table 1. Based on the common HLA-A, HLA-B, and HLA-
DRB1 alleles of these donors, we deduced the probable HLA
haplotype in association with B*58:45 in Taiwanese donors to be
A*33-B*58:45-DRB1*03. Our observations also indicated the
Taiwanese ethnicity of the rare HLA-B allele, B*58:45.
4. Discussion
We conﬁrmed the DNA sequence and amino acid sequence of
the low-frequency HLA allele B*58:45 in this study. B*58:45 was
initially discovered in a Taiwanese individual (Genbank access
number HF933202; IMGT HWS10018426) with HLA typing of A*02,
A*33, B*46:01, B*58:45, DRB1*03, and DRB1*09:01 [1], without
knowledge of the probable HLA haplotype in association with the
allele. In this study, we propose that the deduced probable B*58:46-
associated HLA haplotype to be A*33-B*58:45-DRB1*03 based on
the HLA-A, HLA-B, and HLA-DRB1 alleles shared in common by the
four unrelated bone marrow hematopoietic stem cell donors in ourof B*58:01:01 is replaced by the nucleotide A (shaded) of B*58:45 at residue 595.
Fig. 2. The nucleotide substitution of B*58:45 from B*58:01:01 causes an amino acid replacement at residue 175 where glycine (G) of B*58:01:01 is changed to arginine (R) of
B*58:45 (shaded). AA ¼ amino acid.
Table 1
The HLA-A, HLA-B, and HLA-DRB1 alleles of the donors with B*58:45 and the
deduced probable HLA-A-B-DRB1 haplotype associated with B*58:45.
Donor HLA-A* HLA-B* HLA-DRB1* Deduced probable
B*58:45-associated
HLA-A-B-DRB1 haplotype
346583 11 33 40 58:45 03 03 A*33-B*58:45-DRB1*03
346597 24 33 46:01 58:45 03 09:01 A*33-B*58:45-DRB1*03
370495 02 33 40 58:45 03 15 A*33-B*58:45-DRB1*03
371466 24 33 81 58:45 03 12 A*33-B*58:45-DRB1*03
HLA ¼ human leukocyte antigen.
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probable B*58:45-associated HLA haplotype is most likely
restricted to Taiwanese individuals because, as far as we know,
B*58:45 has only been reported in Taiwanese individuals [7].
Information on the ethnicity of B*58:45 and its linked HLA
haplotype can be used in anthropological investigation of races.
In addition, bone marrow donor registries can allocate appro-
priate unrelated stem cell donors for patients with B*58:45.
Knowing the nucleotide and amino acid variation between
B*58:45 and the prevalently observed B*58:01:01 allele may also
be helpful when selecting a minor HLA-mismatched unrelated
bone marrow stem cell donor for a patient with the rare B*58:45
allele.
It is worth mentioning that the most direct and classic
method of determining HLA haplotypes is through a family study
if test materials from a number of key family members are
available. Alternatively, a population study may be employed if a
sufﬁcient number of unrelated donors are available [8]. However,
the haplotypes deduced via population investigation are
considered to be likely or most probable. In this study, because of
the lack of availability of necessary test material from the fam-
ilies, we opted to determine the haplotypes by looking at the HLA
alleles carried in common by unrelated donors with the same
alleles of interest. By the same token, if determination of plau-
sible HLA-associated haplotypes is for rare- or low-frequency
HLA alleles, the alleles shared in common by unrelated in-
dividuals may be used to deduce the associated probable hap-
lotypes [9e16]. The frequency of B*58:45 in Taiwanese
individuals is extremely low at about one in 10,000 according our
HLA typing practice and the allele frequency reported worldwide
[7]. Therefore, we think the deduced probable B*58:45-
associated HLA haplotypes in Taiwanese individuals that we
deduced in this study are accurate.
The number of known HLA alleles is increasing with the recent
development of DNA-basedmolecular typing technology. There is a
high level of HLA diversity among ethnic groups and knowledge of
this diversity is important. Matching of bone marrow stem cell
donors relies on the accuracy of HLA typing results. This is
dependent on the resolution of unknown, ambiguous, and low-
incidence genes in the HLA system.Acknowledgments
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